$1.82
-0.13-6.67%
At close: -
$1.76
-0.06-3.30%
After Hours: 4:57 PM EDT
Comments
Loading...
SAB Biotherapeutics (SABS) Forecast
NewsEarningsSAB Biotherapeutics (SABS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestSAB Biotherapeutics (NASDAQ:SABS) Stock Quotes, Forecast and News Summary
SAB Biotherapeutics Stock (NASDAQ: SABS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy SAB Biotherapeutics (SABS) stock?
You can purchase shares of SAB Biotherapeutics (NASDAQ:SABS) through any online brokerage.
Who are SAB Biotherapeutics (SABS) competitors?
Other companies in SAB Biotherapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Eterna Therapeutics (NASDAQ:ERNA), CARISMA Therapeutics (NASDAQ:CARM), Cellectar Biosciences (NASDAQ:CLRB) and Evaxion Biotech (NASDAQ:EVAX).
What is the forecast, or price target, for SAB Biotherapeutics (SABS) stock?
SAB Biotherapeutics has a consensus price target of $12.40.
What is the current price for SAB Biotherapeutics (SABS)?
The stock price for SAB Biotherapeutics (NASDAQ: SABS) is $1.76 last updated February 21, 2025 at 4:57 PM EST.
Does SAB Biotherapeutics (SABS) pay a dividend?
There are no upcoming dividends for SAB Biotherapeutics.
When is SAB Biotherapeutics (NASDAQ:SABS) reporting earnings?
SAB Biotherapeutics’s Q1 earnings are confirmed for Monday, May 19, 2025.
Is SAB Biotherapeutics (SABS) going to split?
There is no upcoming split for SAB Biotherapeutics.
What sector and industry does SAB Biotherapeutics (SABS) operate in?
SAB Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.